EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Endocannabinoid system gene expression in mesocorticolimbic brain regions of individuals with alcohol use disorder: A descriptive study

María Salud García-Gutiérrez, Abraham Bailén Torregrosa, Francisco Navarrete, Auxiliadora Aracil-Fernández, Gabriel Rubio, Jorge Manzanares iD

Addiction · 2025

DOI: 10.1111/add.70293 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Addiction, 2025. Verfasst von María Salud García-Gutiérrez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Neurociencias, Campus de San Juan, Universidad Miguel Hernández-CSIC, Alicante, Spain. Hauptthemen laut MEDLINE: Gene Expression, Alcoholism, Endocannabinoids, Prefrontal Cortex. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), NIAAA NIH HHS, National Institutes of Healths.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To describe differences in the expression of genes encoding cannabinoid receptors ( CNR1 , CNR2 ), the associated receptor GRP55 and the enzymes fatty acid amide hydrolase ( FAAH ) and monoacylglycerol lipase ( MGLL ) between individuals with alcohol use disorder (AUD) and controls in key mesocorticolimbic brain regions.

Design

Case‐control, observational postmortem study comparing gene expression in brain tissue from individuals diagnosed with AUD and matched controls. The study was not pre‐registered and should therefore be considered exploratory.

Setting

Brain collection from the New South Wales Tissue Resource Centre (NSWTRC) at the University of Sydney, Australia. Participants/cases Brain samples were obtained from 18 patients with AUD (mean alcohol use = 35.5 ± 8.7 drinking years) and 18 controls (C). Groups were matched for age (AUD: 55.8 ± 9; C: 56.3 ± 9.4) and postmortem interval (AUD: 39.7 ± 16.9 h; C: 31.8 ± 13.2 h).

Measurements

Relative gene expression of CNR1 , CNR2 , GPR55 , FAAH and MGLL was quantified using real‐time polymerase chain reaction (qPCR) in the prefrontal cortex (PFC) and nucleus accumbens (NAc).

Findings

Compared with controls, individuals with AUD showed higher CNR1 in the PFC (+125%) and NAc (+78%) and lower CNR 2 expression in both regions (PFC: −50%; NAc: −49%). GPR55 was higher in the PFC (+19%) and lower in the NAc (−51%). FAAH expression was lower in the PFC (−15%) and higher in the NAc (+24%), whereas MGLL expression did not differ in the PFC and was lower in the NAc (−15%).

Conclusions

This descriptive postmortem study identifying region‐specific differences in endocannabinoid system gene expression between individuals with alcohol use disorder (AUD) and controls supports an involvement of the endocannabinoid system in the neuropathological features associated with AUD, although causal relationships cannot be inferred.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene ExpressionAlcoholismEndocannabinoidsPrefrontal CortexBrainHumansMaleMiddle AgedCase-Control StudiesFemaleAdultAmidohydrolasesReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2Monoacylglycerol LipasesNucleus Accumbens

Stichwörter der Autor:innen

alcohol use disordercannabinoid receptorsendocannabinoid systemgene expressionhuman brainnucleus accumbensprefrontal cortex

Substanzen

AmidohydrolasesReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2Monoacylglycerol LipasesEndocannabinoidsCNR1 protein, humanCNR2 protein, human

Autor:innen und Institutionen

  • Instituto de Neurociencias, Campus de San Juan, Universidad Miguel Hernández-CSIC, Alicante, Spain.
  • Red de Investigación en Atención Primaria de Adicciones, Instituto de Salud Carlos III, MICINN and FEDER, Madrid, Spain.
  • Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
  • Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.
  • Departamento de Psiquiatría, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.
  • Servicio de Psiquiatría, Hospital Universitario 12 de Octubre, Madrid, Spain.

ORCID-Profile: Jorge Manzanares

Förderung

  • Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL)
  • NIAAA NIH HHS
  • National Institutes of Healths
  • The Instituto de Neurociencias is a "Centre of Excellence Severo Ochoa"
  • Ministry of Health
  • National Institutes of Health

Zitieren

APA

García-Gutiérrez, M. S., Torregrosa, A. B., Navarrete, F., Aracil-Fernández, A., Rubio, G., & Manzanares, J. (2025). Endocannabinoid system gene expression in mesocorticolimbic brain regions of individuals with alcohol use disorder: A descriptive study. Addiction. https://doi.org/10.1111/add.70293

Vancouver

García-Gutiérrez MS, Torregrosa AB, Navarrete F, Aracil-Fernández A, Rubio G, Manzanares J. Endocannabinoid system gene expression in mesocorticolimbic brain regions of individuals with alcohol use disorder: A descriptive study. Addiction. 2025. doi:10.1111/add.70293

BibTeX
@article{GarcaGutirrez2025,
  author = {García-Gutiérrez, María Salud and Torregrosa, Abraham Bailén and Navarrete, Francisco and Aracil-Fernández, Auxiliadora and Rubio, Gabriel and Manzanares, Jorge},
  title = {Endocannabinoid system gene expression in mesocorticolimbic brain regions of individuals with alcohol use disorder: A descriptive study},
  journal = {Addiction},
  year = {2025},
  doi = {10.1111/add.70293}
}
Kostenlos starten →